Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02494570 |
Title | A Phase 2 Study of ABI-009 in Patients With Advanced Malignant PEComa |
Acronym | AMPECT |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Aadi, LLC |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Stanford University Medical Center | Palo Alto | California | 94304 | United States | Details | |
Sarcoma Oncology Research Center | Santa Monica | California | 90403 | United States | Details | |
Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
University of Michigan | Ann Arbor | Michigan | 48109 | United States | Details | |
Washington University School of Medicine - Siteman Cancer Center | Saint Louis | Missouri | 63110 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Duke University Medical Center - Duke Cancer Center | Durham | North Carolina | 27710 | United States | Details | |
University of Texas, MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
University of Washington - Seattle Cancer Care Alliance | Seattle | Washington | 98109 | United States | Details |